The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer.
Emma RewcastleIvar SkalandEinar GudlaugssonSilja Kavlie FykseJan P A BaakEmilius A M JanssenPublished in: Breast cancer research and treatment (2024)
This study demonstrates that DIA scoring of Ki67 is superior to manual methods, but further study is required to standardize automated, DIA scoring and definition of a clinical cut-off.